These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 9190900)
21. Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1. Günes C; Lichtsteiner S; Vasserot AP; Englert C Cancer Res; 2000 Apr; 60(8):2116-21. PubMed ID: 10786671 [TBL] [Abstract][Full Text] [Related]
22. Gene-target recognition among members of the myc superfamily and implications for oncogenesis. O'Hagan RC; Schreiber-Agus N; Chen K; David G; Engelman JA; Schwab R; Alland L; Thomson C; Ronning DR; Sacchettini JC; Meltzer P; DePinho RA Nat Genet; 2000 Feb; 24(2):113-9. PubMed ID: 10655054 [TBL] [Abstract][Full Text] [Related]
23. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Wu S; Cetinkaya C; Munoz-Alonso MJ; von der Lehr N; Bahram F; Beuger V; Eilers M; Leon J; Larsson LG Oncogene; 2003 Jan; 22(3):351-60. PubMed ID: 12545156 [TBL] [Abstract][Full Text] [Related]
24. Low molecular weight inhibitors of Myc-Max interaction and function. Yin X; Giap C; Lazo JS; Prochownik EV Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853 [TBL] [Abstract][Full Text] [Related]
25. c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases. Alexandrow MG; Moses HL J Cell Biochem; 1998 Sep; 70(4):528-42. PubMed ID: 9712150 [TBL] [Abstract][Full Text] [Related]
26. Mad1 is a transcriptional repressor of Bcl-6. Lee SC; Bottaro A; Chen L; Insel RA Mol Immunol; 2006 May; 43(12):1965-71. PubMed ID: 16423395 [TBL] [Abstract][Full Text] [Related]
27. Zinc modulates c-Myc/Mad1 balance in human leukemia cells. Sirinian MI; Pisegna S; Paroli M; Militi S; Testa U; Peschle C Leukemia; 2003 Jan; 17(1):272-4. PubMed ID: 12529695 [No Abstract] [Full Text] [Related]
28. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2. Choe C; Chen N; Sawadogo M Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720 [TBL] [Abstract][Full Text] [Related]
29. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity. Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399 [TBL] [Abstract][Full Text] [Related]
30. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc. Yang W; Shen J; Wu M; Arsura M; FitzGerald M; Suldan Z; Kim DW; Hofmann CS; Pianetti S; Romieu-Mourez R; Freedman LP; Sonenshein GE Oncogene; 2001 Mar; 20(14):1688-702. PubMed ID: 11313917 [TBL] [Abstract][Full Text] [Related]
31. The proto-oncogene c-myc in hematopoietic development and leukemogenesis. Hoffman B; Amanullah A; Shafarenko M; Liebermann DA Oncogene; 2002 May; 21(21):3414-21. PubMed ID: 12032779 [TBL] [Abstract][Full Text] [Related]
32. Role of c-myc regulation in Zta-mediated induction of the cyclin-dependent kinase inhibitors p21 and p27 and cell growth arrest. Rodriguez A; Jung EJ; Yin Q; Cayrol C; Flemington EK Virology; 2001 Jun; 284(2):159-69. PubMed ID: 11384216 [TBL] [Abstract][Full Text] [Related]
33. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism. Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166 [TBL] [Abstract][Full Text] [Related]
34. Mmip-2, a novel RING finger protein that interacts with mad members of the Myc oncoprotein network. Yin XY; Gupta K; Han WP; Levitan ES; Prochownik EV Oncogene; 1999 Nov; 18(48):6621-34. PubMed ID: 10597267 [TBL] [Abstract][Full Text] [Related]
35. Analysis of cell cycle arrest in adipocyte differentiation. Reichert M; Eick D Oncogene; 1999 Jan; 18(2):459-66. PubMed ID: 9927202 [TBL] [Abstract][Full Text] [Related]
36. Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms. Elliott K; Sakamuro D; Basu A; Du W; Wunner W; Staller P; Gaubatz S; Zhang H; Prochownik E; Eilers M; Prendergast GC Oncogene; 1999 Jun; 18(24):3564-73. PubMed ID: 10380878 [TBL] [Abstract][Full Text] [Related]
37. Induced p21WAF1 expression acts to reverse myc myelomonocytic cell transformation. Dolnikov A; Millington M; Sun LQ; Symonds G Cancer Gene Ther; 2000 Nov; 7(11):1491-503. PubMed ID: 11129291 [TBL] [Abstract][Full Text] [Related]
38. AP4 encodes a c-MYC-inducible repressor of p21. Jung P; Menssen A; Mayr D; Hermeking H Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15046-51. PubMed ID: 18818310 [TBL] [Abstract][Full Text] [Related]
39. c-Myc induces the expression and activity of ornithine decarboxylase. Wagner AJ; Meyers C; Laimins LA; Hay N Cell Growth Differ; 1993 Nov; 4(11):879-83. PubMed ID: 8297793 [TBL] [Abstract][Full Text] [Related]
40. A new molecular role for iron in regulation of cell cycling and differentiation of HL-60 human leukemia cells: iron is required for transcription of p21(WAF1/CIP1) in cells induced by phorbol myristate acetate. Gazitt Y; Reddy SV; Alcantara O; Yang J; Boldt DH J Cell Physiol; 2001 Apr; 187(1):124-35. PubMed ID: 11241357 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]